引用本文:尹 锐.检测B型尿钠肽对慢性心肾综合征患者诊断和治疗的临床意义[J].中国临床新医学,2013,6(10):980-982.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1406次   下载 947 本文二维码信息
码上扫一扫!
分享到: 微信 更多
检测B型尿钠肽对慢性心肾综合征患者诊断和治疗的临床意义
尹 锐
610050 成都,核工业四一六医院心内科
摘要:
[摘要] 目的 探讨B型尿钠肽(BNP)检测对慢性心肾综合征患者诊断和治疗的临床意义。方法 对该院以心脏疾病为基础病的慢性心力衰竭患者54例的临床资料进行回顾性分析,并按照患者入院时血肌肝(Scr)是否≥133 mmol/L分为单纯慢性心力衰竭组26例和慢性心肾综合征组28例。结果 慢性心肾综合征组的BNP的水平[(1321.5±93.88)pg/L]明显高于单纯慢性心力衰竭组[(865.4±120.32)pg/L](P<0.05)。两组患者的BNP水平均与左室舒张末期内径(LVEDD)呈正相关,与左室射血分数(LVEF)呈负相关(P<0.05)。结论 BNP检测对慢性心肾综合征患者心功能的诊断、病情的判断、指导治疗以及评估预后有重要意义。
关键词:  B型尿钠肽(BNP)  心肾综合征  慢性心力衰竭
DOI:10.3969/j.issn.1674-3806.2013.10.18
分类号:R 542.2
基金项目:
Clinic significance of BNP testing in diagnosis and treatment of patients with chronic cardio-renal syndrome
YIN Rui
Department of Cardiology, the 416 Hospital of Nuclear Industry,Chengdu 610050,China
Abstract:
[Abstract] Objective To understand the clinical significance of BNP in patients with chronic cardio-renal syndrome.Methods The clinical data of 54 chronic heart failure patients with heart disease as underlying disease in the 416 Hospital of Nuclear Industry was retrospectively analyzed.Twenty-six hospitalized patients with simple chronic heart failure(simple heart failure group), and 28 hospitalized patients with chronic cardio-renal syndrome(cardio-renal syndrome group) were retrospectively analyzed.Results The BNP level of chronic cardio-renal syndrome group was significantly higher than that of simple heart failure group[(1321.5± 93.88) vs (865.4 ±120.32)pg/L, P<0.05); The BNP levels of two groups were positively related to the LVEDD and negative related to LVEF(P<0.05).Conclusion BNP can be as applied to cardiac function diagnosis, severity evaluation, therapy guide and prognosis evaluation in patients with chronic cardio-renal syndrome.
Key words:  Brain natriuretic peptide  Cardio-renal syndrome  Chronic heart failure